Cancer cases among transgender and gender-diverse people in England could more than double over the next decade, according to a new study led by Queen Mary University of London. The research, published in eClinicalMedicine, estimates that around 965 new cancer cases currently occur each year in this population. That number could rise to approximately 1,739 cases within five years and 2,257 within ten years.

The study is believed to be the first to estimate annual cancer cases specifically among transgender and gender-diverse people in England. The researchers combined national cancer statistics, population data, and existing evidence on the effects of gender-affirming healthcare to produce their projections.

Breast cancer was estimated to be the most common cancer in this group, accounting for about 19% of cases. Colorectal cancer followed at 12%, and lung cancer at 11%. The researchers also modelled how access to gender-affirming treatments—including hormone therapy and surgery—could affect future cancer rates. Their modelling suggests that access to planned gender-affirming care could reduce the projected number of annual cases in ten years by approximately 11%.

Dr Alison Berner, lead author and Clinical Senior Lecturer in Medical Oncology at Queen Mary, said: “Our research suggests that the number of cancer cases among transgender and gender-diverse people in England could more than double over the next decade. This highlights an important and often overlooked area of cancer care. As this population ages, we need to ensure cancer services are prepared to meet patients’ needs and that everyone can access appropriate screening diagnosis and treatment.”

Dr Chloe Pasin, co-lead author and postdoctoral researcher at Queen Mary, said: “Cancer care is not one-size-fits-all. Our findings suggest that gender-affirming treatments could reduce the likelihood of developing some cancers, while potentially increasing the risk of others. Understanding these differences is essential to care. But we also need better data to build a clearer picture of cancer risks among transgender and gender-diverse people and make sure their needs are not overlooked.”

According to the researchers, the results come from estimates and modeling, not from direct observation. They anticipate the work will aid in shaping future cancer service strategies, medical education, and screening guidelines, as well as enhancing the methods used to gather cancer data.

For university students studying medicine, public health, or health policy, the study underscores a growing need for inclusive healthcare training and data collection. As the transgender population ages, future clinicians and researchers will need to understand how gender-affirming care interacts with cancer risk and screening guidelines. The findings also highlight gaps in current health data systems that students may one day help address.